News
ABVC
1.480
+9.63%
0.130
BACK, ZPTA and ABVC are among premarket gainers
BranchOut Food (BOF) and ZPTA and ABVC are among premarket gainers. Amesite (AMST) launches a revolutionary nurseMagic app. Tesla (TSLA) has analysts buzzing after Elon Musk says it is now an AI robotics company.
Seeking Alpha · 22h ago
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results. Tesla posted weaker-than-expected earnings and sales results for its first quarter on Tuesday. The electric vehicle giant also announced plans to speed up the launch of new models. Chicken Soup for the Soul Entertainment shares gained 49.4% in pre- market trading.
Benzinga · 23h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. ABVC BioPharma and Medpace Hldgs stock increased by 5.15%. Fresh2 Group shares fell 12.9% during the session.
Benzinga · 1d ago
Weekly Report: what happened at ABVC last week (0415-0419)?
Weekly Report · 3d ago
AiBtl BioPharma Inc. Acquired TT Life Company, Valued At $8.33M, With 1.66M AiBtl Shares At $5 per Share
AiBtl BioPharma Inc. Acquired TT Life Company, an established player in the precision medicine industry. The acquisition brings together AiBtl's global development and scaling expertise with TT Life's design and manufacturing capabilities in precision medicine. The company aims to deliver groundbreaking products integrating AI intelligence with everyday life.
Benzinga · 6d ago
ABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404
NASDAQ · 04/17 13:48
ABVC BioPharma executes licensing agreement with OncoX
Seeking Alpha · 04/17 13:19
ABVC BioPharma Executes A Global Licensing Definitive Agreement For The Treatment Of NSCLC, Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M
ABVC BioPharma, Inc. Has entered into a licensing agreement with OncoX for the treatment of Non-Small Cell Lung Cancer. BLEX 404 is a botanical drug extract from the dry fruit body of maitake mushrooms. The active ingredient of blex 404 is the beta-glucan extracted from the mushrooms. ABVC is a clinical-stage biopharmaceutical company developing treatments for cancer.
Benzinga · 04/17 13:01
ABVC BIOPHARMA EXECUTES A GLOBAL LICENSING DEFINITIVE AGREEMENT FOR THE TREATMENT OF NSCLC, EXPECTING AGGREGATE INCOME OF $13.75M AND ROYALTIES OF UP TO $12.50M
Reuters · 04/17 13:00
ABVC BIOPHARMA INC - TO RECEIVE $12.5M LICENSE FEE FROM ONCOX
Reuters · 04/17 13:00
Weekly Report: what happened at ABVC last week (0408-0412)?
Weekly Report · 04/15 10:58
12 Health Care Stocks Moving In Wednesday's After-Market Session
Rallybio shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by 10.52% during the session.
Benzinga · 04/10 20:31
ABVC Biopharma stock climbs on deal for its oncology/hematology products
ABVC Biopharma stock climbs on deal for its oncology/hematology products. ABVC BioPharma shares rise about 14% after entering into a term sheet with OncoX for the company's pipeline. The company is set to receive $50M as licensing fees.
Seeking Alpha · 04/10 13:23
Market-Moving News for April 10th
Adial Pharmaceuticals shares are trading higher after publication of a peer-reviewed article on AD04. The company's stock is up 108%. Nano Labs and ABVC BioPharma are also trading higher. Adial's AD04 has strong clinical results and a strong safety profile.
Benzinga · 04/10 12:39
ABVC BIOPHARMA EXECUTES A GLOBAL LICENSING TERM SHEET FOR ONCOLOGY/HEMATOLOGY PRODUCTS, EXPECTING LICENSING INCOME OF $55M AND ROYALTIES OF UP TO $50M
Reuters · 04/10 12:32
Weekly Report: what happened at ABVC last week (0401-0405)?
Weekly Report · 04/08 11:03
12 Health Care Stocks Moving In Monday's After-Market Session
OpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. Kyverna Therapeutics shares increased by 9.19%. Galecto and Ontrak also gained ground. Gritstone Bio and Aclarion were among the losers in the market.
Benzinga · 04/01 20:31
Weekly Report: what happened at ABVC last week (0325-0329)?
Weekly Report · 04/01 11:01
VERI, CHEK and MESO are among pre market gainers
VERI, CHEK and MESO are among pre market gainers. Mesoblast (MESO) and Cazoo Group (CZOO) are among the biggest pre market losers. Krispy Kreme and AirNet Technology are also on the move.
Seeking Alpha · 03/27 12:24
Why ABVC BioPharma Stock Is Up Today
ABVC BioPharma, Inc. Has entered into a global licensing agreement with ForSeeCon Eye Corporation for the company’s ophthalmology pipeline. ABVC shares are trading higher Tuesday. The company does not pay a dividend, but ABVC has a few ways to return value to shareholders.
Benzinga · 03/26 16:23
More
Webull provides a variety of real-time ABVC stock news. You can receive the latest news about Abvc Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About ABVC
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1519 is used for the treatment of non-small cell lung cancer. ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. The Company develops drugs and medical devices derived from plants.